Role of HPV16 E1 in cervical carcinogenesis
- PMID: 35967849
- PMCID: PMC9368317
- DOI: 10.3389/fcimb.2022.955847
Role of HPV16 E1 in cervical carcinogenesis
Abstract
Cervical cancer is the fourth most common cancer in women worldwide. More than 90% of cases are caused by the human papillomavirus (HPV). Vaccines developed only guard against a few HPV types and do not protect people who have already been infected. HPV is a small DNA virus that infects the basal layer of the stratified epithelium of the skin and mucosa through small breaks and replicates as the cells differentiate. The mucosal types of HPV can be classified into low-risk and high-risk groups, based on their association with cancer. Among HPV types in high-risk group, HPV type 16 (HPV-16) is the most common, causing 50% of all cancer cases. HPV infection can occur as transient or persistent infections, based on the ability of immune system to clear the virus. Persistent infection is characterized by the integration of HPV genome. HPV-16 exhibits a different integration pattern, with only 50% reported to be integrated at the carcinoma stage. Replication of the HPV genome depends on protein E1, an ATP-dependent helicase. E1 is essential for the amplification of the viral episome in infected cells. Previous studies have shown that E1 does not only act as a helicase protein but is also involved in recruiting and interacting with other host proteins. E1 has also been deemed to drive host cell proliferation. Recent studies have emphasized the emerging role of HPV E1 in cervical carcinogenesis. In this review, a possible mechanism by which E1 drives cell proliferation and oncogenesis will be discussed.
Keywords: HPV; HPV16; HPV16 E1; cervical cancer; cervical carcinogenesis.
Copyright © 2022 Baedyananda, Sasivimolrattana, Chaiwongkot, Varadarajan and Bhattarakosol.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Determination of human papillomavirus 16 physical status through E1/E6 and E2/E6 ratio analysis.J Med Microbiol. 2014 Dec;63(Pt 12):1716-1723. doi: 10.1099/jmm.0.076810-0. Epub 2014 Sep 11. J Med Microbiol. 2014. PMID: 25212758
-
Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.J Med Microbiol. 2020 Jul;69(7):960-970. doi: 10.1099/jmm.0.001213. J Med Microbiol. 2020. PMID: 32510304 Free PMC article.
-
Replication interference between human papillomavirus types 16 and 18 mediated by heterologous E1 helicases.Virol J. 2014 Jan 24;11:11. doi: 10.1186/1743-422X-11-11. Virol J. 2014. PMID: 24456830 Free PMC article.
-
APOBEC-mediated genomic alterations link immunity and viral infection during human papillomavirus-driven cervical carcinogenesis.Biosci Trends. 2017 Sep 12;11(4):383-388. doi: 10.5582/bst.2017.01103. Epub 2017 Jul 17. Biosci Trends. 2017. PMID: 28717061 Review.
-
Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy.Biochemistry (Mosc). 2019 Jul;84(7):782-799. doi: 10.1134/S0006297919070095. Biochemistry (Mosc). 2019. PMID: 31509729 Review.
Cited by
-
Advances in cervical cancer: current insights and future directions.Cancer Commun (Lond). 2025 Feb;45(2):77-109. doi: 10.1002/cac2.12629. Epub 2024 Nov 29. Cancer Commun (Lond). 2025. PMID: 39611440 Free PMC article. Review.
-
EZH2 regulates tumor-associated macrophages by the KDM6A-mediated inflammatory response in HPV16-positive cervical cancer.Hum Cell. 2025 Jun 19;38(4):119. doi: 10.1007/s13577-025-01246-3. Hum Cell. 2025. PMID: 40536676
-
HPV16E1 downregulation altered the cell characteristics involved in cervical cancer development.Sci Rep. 2023 Oct 25;13(1):18217. doi: 10.1038/s41598-023-45339-1. Sci Rep. 2023. PMID: 37880374 Free PMC article.
-
Upregulation of HPV16E1 and E7 expression and FOXO3a mRNA downregulation in high-grade cervical neoplasia.PeerJ. 2024 Dec 6;12:e18601. doi: 10.7717/peerj.18601. eCollection 2024. PeerJ. 2024. PMID: 39655333 Free PMC article.
-
Comparative Molecular Docking of Apigenin and Luteolin versus Conventional Ligands for TP-53, pRb, APOBEC3H, and HPV-16 E6: Potential Clinical Applications in Preventing Gynecological Malignancies.Curr Issues Mol Biol. 2024 Oct 3;46(10):11136-11155. doi: 10.3390/cimb46100661. Curr Issues Mol Biol. 2024. PMID: 39451541 Free PMC article.
References
-
- Acheson N. H. (2011). Fundamentals of Molecular Virology. (Hoboken, New Jersey), USA: John Wiley & Sons, INC. (John Wiley & Sons, INC; ).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources